Inherited cardiomyopathies

Circulation Journal

Volumn 78, Issue 10, 2014, Pages 2347-2356

  Towbin, Jeffrey A ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Cardiomyopathy; Genetics; Heart failure

Indexed keywords

ALPHA ACTININ 2; ALPHA CATENIN; ALPHA CRYSTALLIN; ALPHA GALACTOSIDASE; ALPHA TROPOMYOSIN; ANKYRIN; BAG 1 PROTEIN; CARDIOTROPHIN 1; CAVEOLIN 3; CONNECTIN; DESMIN; DESMOCOLLIN; DYSTROBREVIN; DYSTROPHIN; EMERIN; FUKUTIN; GAMMA SARCOGLYCAN; LAMIN A; LAMIN C; MYOSIN BINDING PROTEIN C; MYOSIN HEAVY CHAIN BETA; MYOSIN LIGHT CHAIN 2; PHOSPHOLAMBAN; PLAKOPHILIN; PREALBUMIN; PRESENILIN 1; PRESENILIN 2; PROTEIN P20; UNINDEXED DRUG; VINCULIN;

AUTOSOMAL DOMINANT INHERITANCE; CARDIOMYOPATHY; CONGESTIVE CARDIOMYOPATHY; DESMOSOME; DIASTOLIC DYSFUNCTION; ECHOCARDIOGRAPHY; GENE MUTATION; GENETIC DISORDER; GENETICS; HEART FAILURE; HEART RIGHT VENTRICLE DYSPLASIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERLAPPING GENE; PATHOGENESIS; PHENOTYPE; RESTRICTIVE CARDIOMYOPATHY; REVIEW; SARCOLEMMA; SARCOMERE; SUDDEN CARDIAC DEATH; SYSTOLIC DYSFUNCTION; VENTRICULAR NONCOMPACTION; ANIMAL; CONGENITAL HEART MALFORMATION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE; METABOLISM; MORTALITY; MUTATION;

ANIMALS; CARDIOMYOPATHY, DILATED; GENETIC DISEASES, INBORN; HEART DEFECTS, CONGENITAL; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MUTATION; MYOCARDIUM;

EID: 84908256079     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-14-0893     Document Type: Review

References (83)

1. Lee CS, Chien CV, Bidwell JT, Gelow JM, Denfeld QE, Creber RM, et al. Comorbidity profiles and inpatient outcomes during hospitalization for heart failure: An analysis of the U.S. Nationwide inpatient sample. BMC Cardiovasc Disord 2014; 14: 73.
2. Shamszad P, Hall M, Rossano JW, Denfield SW, Knudson JD, Penny DJ, et al. Characteristics and outcomes of heart failure-related intensive care unit admissions in children with cardiomyopathy. J Card Fail 2013; 19: 672-677.
3. Cahill TJ, Ashrafian H, Watkins H. Genetic cardiomyopathies causing heart failure. Circ Res 2013; 113: 660-675.
4. Teekakirikul P, Kelly MA, Rehm HL, Lakdawala NK, Funke BH. Inherited cardiomyopathies: Molecular genetics and clinical genetic testing in the postgenomic era. J Mol Diagn 2013; 15: 158-167.
5. Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, et al. Contemporary definitions and classification of the cardiomyopathies: An American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006 113: 1807-1816.
6. Bowles NE, Bowles KR, Towbin JA. The “final common pathway” hypothesis and inherited cardiovascular disease: The role of cytoskeletal proteins in dilated cardiomyopathy. Herz 2000; 25: 168-175.
7. Ellinor PT, MacRae CA, Thierfelder L. Arrhythmogenic right ventricular cardiomyopathy. Heart Fail Clin 2010; 6: 161-177.
8. Sen-Chowdhry S, Syrris P, McKenna WJ. Genetics of restrictive cardiomyopathy. Heart Fail Clin 2010; 6: 179-186.
9. Towbin JA, Lowe AM, Colan SD, Sleeper LA, Orav EJ, Clunie S, et al. Incidence, causes and outcomes of dilated cardiomyopathy in children. JAMA 2006; 296: 1867-1876.
10. Fatkin D; members of the CSANZ Cardiac Genetic Diseases Council Writing Group. Guidelines for the diagnosis and management of familial dilated cardiomyopathy. Heart Lung Circ 2011; 20: 691-693.
11. Givertz MM, Mann DL. Epidemiology and natural history of recovery of left ventricular function in recent onset dilated cardiomyopathies. Curr Heart Fail Rep 2013; 10: 321-330.
12. Dec GW, Fuster V. Idiopathic dilated cardiomyopathy. N Engl J Med 1994; 331: 1564-1575.
13. Ackerman MJ, Priori SG, Willems S, Berul C, Brugada R, Calkins H, et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm 2011; 8: 1308-1339.
14. Finsterer J, Stöllberger C, Wahbi K. Cardiomyopathy in neurological disorders. Cardiovasc Pathol 2013; 22: 389-400.
15. Hershberger RE, Lindenfeld J, Mestroni L, Seidman CE, Taylor MR, Towbin JA; Heart Failure Society of America. Genetic evaluation of cardiomyopathy: A Heart Failure Society of America practice guideline. J Card Fail 2009; 15: 83-97.
16. Towbin JA, Bowles NE. The failing heart. Nature 2002; 415: 227-233.
17. Towbin JA, Hejtmancik JF, Brink P, Gelb B, Zhu XM, Chamberlain JS, et al. X-linked dilated cardiomyopathy (XLCM): Molecular genetic evidence of linkage to the Duchenne muscular dystrophy gene at the Xp21 locus. Circulation 1993; 87: 1854-1865.
18. Muntoni F, Cau M, Ganau A, Congiu R, Arvedi G, Mateddu A, et al. Brief report: Deletion of the dystrophin muscle-specific promoter region associated with X-linked dilated cardiomyopathy. N Engl J Med 1993; 329: 921-925.
19. Diegoli M, Grasso M, Favalli V, Serio A, Gambarin FI, Klersy C, et al. Diagnostic work-up and risk stratification in X-linked dilated cardiomyopathies caused by dystrophin defects. J Am Coll Cardiol 2011; 58: 925-934.
20. Rahimov F, Kunkel LM. The cell biology of disease: Cellular and molecular mechanisms underlying muscular dystrophy. J Cell Biol 2013; 201: 499-510.
21. Constantin B. Dystrophin complex functions as a scaffold for signalling proteins. Biochim Biophys Acta 2014; 1838: 635-642.
22. Chelly J, Desguerre I. Progressive muscular dystrophies. Handb Clin Neurol 2013; 113: 1343-1366.
23. Morales A, Hershberger RE. Genetic evaluation of dilated cardiomyopathy. Curr Cardiol Rep 2013; 15: 375, doi:10.1007/s11886-013-0375-1.
24. Mestroni L, Taylor MR. Genetics and genetic testing of dilated cardiomyopathy: A new perspective. Discov Med 2013; 15: 43-49.
25. Garcia-Pavia P, Syrris P, Salas C, Evans A, Mirelis JG, Cobo-Marcos M, et al. Desmosomal protein gene mutations in patients with idiopathic dilated cardiomyopathy undergoing cardiac transplantation: A clinicopathological study. Heart 2011; 97: 1744-1752.
26. Wolf CM, Wang L, Alcalai R, Pizard A, Burgon PG, Ahmad F, et al. Lamin A/C haploinsufficiency causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction system disease. J Mol Cell Cardiol 2008; 44: 293-303.
27. Taylor MR, Slavov D, Ku L, Di Lenarda A, Sinagra G, Carniel E, et al. Prevalence of desmin mutations in dilated cardiomyopathy. Circulation 2007; 115: 1244-1251.
28. Debold EP, Schmitt JP, Patlak JB, Beck SE, Moore JR, Seidman JG, et al. Hypertrophic and dilated cardiomyopathy mutations differentially affect the molecular force generation of mouse alpha-cardiac myosin in the laser trap assay. Am J Physiol Heart Circ Physiol 2007; 293: H284-H291.
29. Ehler E, Perriard JC. Cardiomyocyte cytoskeleton and myofibrillogenesis in healthy and diseased heart. Heart Fail Rev 2000; 5: 259-269.
30. Basso C, Czarnowska E, Della Barbera M, Bauce B, Beffagna G, Wlodarska EK, et al. Ultrastructural evidence of intercalated disc remodelling in arrhythmogenic right ventricular cardiomyopathy: An electron microscopy investigation on endomyocardial biopsies. Eur Heart J 2006; 27: 1847-1854.
31. Yang Z, Bowles NE, Scherer SE, Taylor MD, Kearney DL, Ge S, et al. Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Res 2006; 99: 646-655.
32. Purevjav E, Arimura T, Augustin S, Huby AC, Takagi K, Nunoda S, et al. Molecular basis for clinical heterogeneity in inherited cardiomyopathies due to myopalladin mutations. Hum Mol Genet 2012; 21: 2039-2053.
33. Purevjav E, Varela J, Morgado M, Kearney DL, Li H, Taylor MD, et al. Nebulette mutations are associated with dilated cardiomyopathy and endocardial fibroelastosis. J Am Coll Cardiol 2010; 56: 1493-1502.
34. Fatkin D, Graham RM. Molecular mechanisms of inherited cardiomyopathies. Physiol Ref 2002 ; 82: 945-980.
35. McNally EM, Golbus JR, Puckelwartz MJ. Genetic mutations and mechanisms in dilated cardiomyopathy. J Clin Invest 2013; 123: 19-26.
36. Olson TM, Michels VV, Thibodeau SN, Tai YS, Keating MT. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science 1998; 280: 750-752.
37. Kamisago M, Sharma SD, DePalma SR, Solomon S, Sharma P, McDonough B, et al. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med 2000; 343: 1688-1696.
38. Pyle WG, Solaro RJ. At the crossroads of myocardial signaling: The role of Z-discs in intracellular signaling and cardiac function. Circ Res 2004; 94: 296-305.
39. Knoll R, Hoshijima M, Hoffman HM, Person V, Lorenzen-Schmidt I, Bang ML, et al. The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy. Cell 2002; 11: 943-955.
40. Vatta M, Sinagra G, Brunelli L, Faulkner G. Remodeling of dystrophin and sarcomeric Z-band occurs in pediatric cardiomyopathies: A unifying mechanism for force transmission defect. J Cardiovasc Med (Hagerstown) 2009; 10: 149-156.
41. Mohapatra B, Jimenez S, Lin JH, Bowles KR, Coveler KJ, Marx JG, et al. Mutations in the muscle LIM protein and α-actinin-2 genes in dilated cardiomyopathy and endocardial fibroelastosis. Mol Genet Metab 2003; 80: 207-215.
42. Lin X, Ruiz J, Bajraktari I, Ohman R, Banerjee S, Gribble K, et al. Z-disc-associated, alternatively spliced, PDZ motif-containing protein (ZASP) mutations in the actin-binding domain cause disruption of skeletal muscle actin filaments in myofibrillar myopathy. J Biol Chem 2014; 289: 13615-13626.
43. Martinelli VC, Kyle WB, Kojic S, Vitulo N, Li Z, Belgrano A, et al. ZASP interacts with the mechanosensing protein Ankrd2 and p53 in the signalling network of striated muscle. PLoS One 2014; 9: e92259, doi:10.1371/journal.pone.0092259.
44. LeWinter MM, Granzier HL. Cardiac titin and heart disease. J Cardiovasc Pharmacol 2014; 63: 207-212.
45. Maron BJ, Maron MS. Hypertrophic cardiomyopathy. Lancet 2013; 381: 242-255.
46. O’Mahony C, Elliott PM. Prevention of sudden cardiac death in hypertrophic cardiomyopathy. Heart 2014; 100: 254-260.
47. Marston S, Copeland O, Jacques A, Livesey K, Tsang V, McKenna WJ, et al. Evidence from human myectomy samples that MYBPC3 mutations cause hypertrophic cardiomyopathy through haploinsufficiency. Circ Res 2009; 105: 219-222.
48. Lopes LR, Zekavati A, Syrris P, Hubank M, Giambartolomei C, Dalageorgou C, et al. Genetic complexity in hypertrophic cardiomyopathy revealed by high-throughput sequencing. J Med Genet 2013; 50: 228-239.
49. Ho CY. Genetics and clinical destiny: Improving care in hypertrophic cardiomyopathy. Circulation 2010; 122: 2430-2440.
50. Bos JM, Will ML, Gersh BJ, Kruisselbrink TM, Ommen SR, Ackerman MJ. Characterization of a phenotype-based genetic test prediction score for unrelated patients with hypertrophic cardiomyopathy. Mayo Clin Proc 2014; 89: 727-737.
51. Lopes LR, Rahman MS, Elliott PM. A systematic review and metaanalysis of genotype-phenotype associations in patients with hypertrophic cardiomyopathy caused by sarcomeric protein mutations. Heart 2013; 99: 1800-1811.
52. Bos JM, Towbin JA, Ackerman MJ. Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy. J Am Coll Cardiol 2009; 54: 201-211.
53. Theis JL, Bos JM, Bartleson VB, Will ML, Binder J, Vatta M, et al. Echocardiographic-determined septal morphology in Z-disc hypertrophic cardiomyopathy. Biochem Biophys Res Commun 2006; 351: 896-902.
54. Geske JB, Bos JM, Gersh BJ, Eidem BW, Ackerman MJ. Deformation patterns in genotyped patients with hypertrophic cardiomyopathy. Eur Heart J Cardiovasc Imaging 2014; 15: 456-465.
55. Rivenes SM, Kearney DL, Smith EO, Towbin JA, Denfield SW. Sudden death and cardiovascular collapse in children with restrictive cardiomyopathy. Circulation 2000; 102: 876-882.
56. Walsh MA, Grenier MA, Jefferies JL, Towbin JA, Lorts A, Czosek RJ. Conduction abnormalities in pediatric patients with restrictive cardiomyopathy. Circ Heart Fail 2012; 5: 267-273.
57. Caleshu C, Sakhuja R, Nussbaum RL, Schiller NB, Ursell PC, Eng C, et al. Furthering the link between the sarcomere and primary cardiomyopathies: Restrictive cardiomyopathy associated with multiple mutations in genes previously associated with hypertrophic or dilated cardiomyopathy. Am J Med Genet A 2011; 155A: 2229-2235.
58. Towbin JA. Left ventricular noncompaction: A new form of heart failure. Heart Fail Clin 2010; 6: 453-469.
59. Ichida F, Hamamichi Y, Miyawaki T, Ono Y, Kamiya T, Akagi T, et al. Clinical features of isolated noncompaction of the ventricular myocardium: Long-term clinical course, hemodynamic properties, and genetic background. J Am Coll Cardiol 1999; 34: 233-240.
60. Sasse-Klaassen S, Gerull B, Oechslin E, Jenni R, Thierfelder L. Isolated noncompaction of the left ventricular myocardium in the adult is an autosomal dominant disorder in the majority of patients. Am J Med Genet A 2003; 119A: 162-167.
61. Stahli BE, Gebhard C, Biaggi P, Klaassen S, Valsangiacomo Buechel E, Attenhofer Jost CH, et al. Left ventricular non-compaction: Prevalence in congenital heart disease. Int J Cardiol 2013; 167: 2477-2481.
62. Bleyl SB, Mumford BR, Brown-Harrison MC, Pagotto LT, Carey JC, Pysher TJ, et al. Xq28-linked noncompaction of the left ventricular myocardium: Prenatal diagnosis and pathologic analysis of affected individuals. Am J Med Genet 1997; 72: 257-265.
63. Udeoji DU, Philip KJ, Morrissey RP, Phan A, Schwarz ER. Left ventricular noncompaction cardiomyopathy: Updated review. Ther Adv Cardiovasc Dis 2013; 7: 260-273.
64. Ouyang P, Saarel E, Bai Y, Luo C, Lv Q, Xu Y, et al. A de novo mutation in NKX2.5 associated with atrial septal defects, ventricular noncompaction, syncope and sudden death. Clin Chim Acta 2011; 412: 170-175.
65. Postma AV, van Engelen K, van de Meerakker J, Rahman T, Probst S, Baars MJ, et al. Mutations in the sarcomere gene MYH7 in Ebstein anomaly. Circ Cardiovasc Genet 2011; 4: 43-50.
66. Vermeer AM, van Engelen K, Postma AV, Baars MJ, Christiaans I, De Haij S, et al. Ebstein anomaly associated with left ventricular noncompaction: An autosomal dominant condition that can be caused by mutations in MYH7. Am J Med Genet C Semin Med Genet 2013; 163C: 178-184.
67. Probst S, Oechslin E, Schuler P, Greutmann M, Boyé P, Knirsch W, et al. Sarcomere gene mutations in isolated left ventricular noncompaction cardiomyopathy do not predict clinical phenotype. Circ Cardiovasc Genet 2011; 4: 367-374.
68. Hoedemaekers YM, Caliskan K, Michels M, Frohn-Mulder I, van der Smagt JJ, Phefferkorn JE, et al. The importance of genetic counseling, DNA diagnostics, and cardiologic family screening in left ventricular noncompaction cardiomyopathy. Circ Cardiovasc Genet 2010; 3: 232-239.
69. Dellefave LM, Pytel P, Mewborn S, Mora B, Guris DL, Fedson S, et al. Sarcomere mutations in cardiomyopathy with left ventricular hypertrabeculation. Circ Cardiovasc Genet 2009; 2: 442-449.
70. Shieh JT. Implications of genetic testing in noncompaction/hypertrabeculation. Am J Med Genet C Semin Med Genet 2013; 163C: 206-211.
71. Protonotarios N, Tsatsopoulou A. Naxos disease and Carvajal syndrome: Cardiocutaneous disorders that highlight the pathogenesis and broaden the spectrum of arrhythmogenic right ventricular cardiomyopathy. Cardiovasc Pathol 2004; 13: 185-194.
72. Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, Bluemke DA, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/ dysplasia: Proposed modification of the task force criteria. Circulation 2010; 121: 1533-1541.
73. Azaouagh A, Churzidse S, Konorza T, Erbel R. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: A review and update. Clin Res Cardiol 2011; 100: 383-394.
74. Herren T, Gerber PA, Duru F. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: A not so rare “disease of the desmosome” with multiple clinical presentations. Clin Res Cardiol 2009; 98: 141-158.
75. Hamid MS, Norman M, Quraishi A, Firoozi S, Thaman R, Gimeno JR, et al. Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy/dysplasia reveals a need to broaden diagnostic criteria. J Am Coll Cardiol 2002; 40: 1445-1450.
76. Te Rijdt WP, Jongbloed JD, de Boer RA, Thiene G, Basso C, van den Berg MP, et al. Clinical utility gene card for: Arrhythmogenic right ventricular cardiomyopathy (ARVC). Eur J Hum Genet 2014; 22, doi:10.1038/ejhg.2013.124.
77. Xu T, Yang Z, Vatta M, Rampazzo A, Beffagna G, Pilichou K, et al. Compound and digenic heterozygosity contributes to arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol 2010; 55: 587-597.
78. Bauce B, Nava A, Beffagna G, Basso C, Lorenzon A, Smaniotto G, et al. Multiple mutations in desmosomal proteins encoding genes in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Heart Rhythm 2010; 7: 22-29.
79. Patel DM, Green KJ. Desmosomes in the heart: A review of clinical and mechanistic analyses. Cell Commun Adhes 2014; 21: 109-128.
80. Vatta M, Marcus F, Towbin JA. Arrhythmogenic right ventricular cardiomyopathy: A ‘final common pathway’ that defines clinical phenotype. Eur Heart J 2007; 28: 529-530
81. Delmar M, McKenna WJ. The cardiac desmosome and arrhythmogenic cardiomyopathies: From gene to disease. Circ Res 2010; 107: 700-714.
82. Noorman M, Hakim S, Kessler E, Groeneweg JA, Cox MG, Asimaki A, et al. Remodeling of the cardiac sodium channel, connexin43, and plakoglobin at the intercalated disk in patients with arrhythmogenic cardiomyopathy. Heart Rhythm 2013; 10: 412-419.
83. Towbin JA, Lorts A. Arrhythmias and dilated cardiomyopathy common pathogenetic pathways? J Am Coll Cardiol 2011; 57: 2169-2171.